MEDICO.NS
Key Ratios

Net Profit Margin: Making moderate profit when compared with its revenue which generally means a slow or stable business or a small company who just started making profit

Acid Test Ratio: It has good liquidity, which means it can can cover its liabilities without relying on inventory

Inventory Turnover: High efficiency of inventory movement which means good inventory management

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

P/E Ratio: Overvalued stock which means company is making very less revenue per share but stock price is very high which represent speculative stock

Performance Graph
Financial Ratios
Ratio Value
PE Ratio55.84
Net Profit Margin0.06
Acid Test Ratio1.34
Inventory Turnover7.26
Coverage Ratio6.84
Debt to Equity0.15
Key Ratios

Net Profit Margin: Making moderate profit when compared with its revenue which generally means a slow or stable business or a small company who just started making profit

Return on Assets: Very high efficiency of the assets which indicates assets are making high contribution to the revenue

Return on Equity: Giving good returns on equity which is generally acceptable for most industries

Performance Graph
Profitability Ratios
Ratio Value
Net Profit Margin0.06
Return on Assets1.94
Return on Equity0.16
Performance Graph
Key Ratios

Acid Test Ratio: It has good liquidity, which means it can can cover its liabilities without relying on inventory

Current Ratio: It has a good balance between assets & liabilities and would be just able to cover its short-term liabilities

Performance Graph
Liquidity Ratios
Ratio Value
Acid Test Ratio1.34
Current Ratio1.72
Performance Graph
Key Ratios

Inventory Turnover: High efficiency of inventory movement which means good inventory management

Performance Graph
Efficiency Ratios
Ratio Value
Inventory Turnover7.26
Performance Graph
Key Ratios

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Performance Graph
Coverage Ratios
Ratio Value
Coverage Ratio6.84
Performance Graph
Key Ratios

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

Interest Coverage Ratio: Company is at low risk of getting default as it can easily cover its interest payments and strong financial health

Performance Graph
Solvency Ratios
Ratio Value
Debt to Equity Ratio0.15
Interest Coverage Ratio18.64
Performance Graph
Key Ratios

P/E Ratio: Overvalued stock which means company is making very less revenue per share but stock price is very high which represent speculative stock

Dividend Yield: NA

Performance Graph
Market Ratios
Ratio Value
P/E Ratio55.84
Gross Profit Margin0.17
Price to Book Ratio8.84
Dividend Yield0.00
Performance Graph

Balance Sheet Analysis of Medico Remedies Limited

The balance sheet in the financial statement of the company shows its financial position at a particular point in time.

It consists of the following:

  • Assets: Something that the company owns and that gives financial benefits over a period of time.
  • Liabilities: Something that a company owes and that has a financial burden on the company.
  • Equity: It is basically the owner’s share in the company.

The formula is:

Assets = Liabilities + Equity
đź“ŚAssets:
Asset
Value & Year
2024
2023
2022
Total Assets 961953000 874483000 774042000
Total Non Current Assets 224307000 229089000 198316000
Other Non Current Assets 1000 2153000 -1000
Non Current Prepaid Assets 5639000 8036000 8329000
Non Current Deferred Taxes Assets - - 1858000
Financial Assets - - -
Investment In Financial Assets 2025000 - -
Held To Maturity Securities - - -
Available For Sale Securities 2025000 7939000 -
Financial Assets Fair Value - - -
Long Term Equity Investment - - -
Investments In Associates At Cost - - -
Goodwill And Other Intangible Assets 1205000 700000 -
Other Intangible Assets 1205000 700000 -
Goodwill - - -
Net Ppe 213735000 218851000 186615000
Accumulated Depreciation -198315000 -175203000 -143600000
Gross Ppe 412050000 394054000 330215000
Construction In Progress - 554000 6277000
Other Properties 5384000 4445000 1579000
Machinery Furniture Equipment 206792000 187912000 145593000
Buildings And Improvements 176795000 178064000 153687000
Land And Improvements 23079000 23079000 23079000
Properties - - -
Current Assets 737647000 645394000 575727000
Other Current Assets 1082000 969000 5471000
Hedging Assets Current - - -
Assets Held For Sale Current - - -
Restricted Cash - - -
Prepaid Assets 3675000 2368000 1622000
Inventory 163372000 196987000 181078000
Other Inventories 26600000 29331000 45424000
Finished Goods 15265000 53570000 41297000
Work In Process 54802000 36867000 37339000
Raw Materials 66705000 77219000 57018000
Other Receivables 1994000 1702000 2650000
Taxes Receivable 55736000 60648000 62995000
Accounts Receivable 496330000 360949000 303943000
Allowance For Doubtful Accounts Receivable -8483000 -7733000 -9120000
Gross Accounts Receivable 504813000 368682000 313063000
Cash Cash Equivalents And Short Term Investments 15458000 21771000 23439000
Other Short Term Investments 13631000 12657000 11789000
Cash And Cash Equivalents 1827000 9114000 11650000
Cash Equivalents - - 11800000
Cash Financial 1827000 9114000 11650000
đź“Ś Liabilities & Equity
Liability/Equity
Value & Year
2024
2023
2022
Net Debt 65692000 71819000 94512000
Total Debt 80505000 97616000 125971000
Total Liabilities Net Minority Interest 438244000 436053000 408296000
Total Non Current Liabilities Net Minority Interest 10101000 18353000 26898000
Other Non Current Liabilities -1000 1000 -1000
Derivative Product Liabilities - - -
Non Current Pension And Other Postretirement Benefit Plans - 634000 484000
Trade And Other Payables Non Current - 2876000 716000
Non Current Deferred Revenue - - -
Non Current Deferred Taxes Liabilities 1429000 1855000 -
Long Term Debt And Capital Lease Obligation 8672000 12987000 25699000
Long Term Capital Lease Obligation 8672000 12987000 16683000
Long Term Debt - - 9016000
Long Term Provisions - 634000 484000
Current Liabilities 428143000 417700000 381398000
Other Current Liabilities 1000 14195000 6819000
Current Deferred Taxes Liabilities - - -
Current Debt And Capital Lease Obligation 71833000 84629000 100272000
Current Capital Lease Obligation 4314000 3696000 3126000
Current Debt 67519000 80933000 97146000
Pension And Other Post Retirement Benefit Plans Current - 376000 431000
Current Provisions - 376000 4000000
Payables 342300000 328432000 279331000
Other Payable 15008000 9050000 3714000
Dividends Payable - - -
Total Tax Payable 12172000 9524000 4648000
Accounts Payable 315120000 309858000 270969000
Common Stock Equity 523709000 438430000 365746000
Total Capitalization 523709000 438430000 374762000
Total Equity Gross Minority Interest 523709000 438430000 365746000
Minority Interest - - -
Stockholders Equity 523709000 438430000 365746000
Other Equity Interest 357742000 272462000 -
Treasury Stock - - -
Retained Earnings 322070000 239161000 166746000
Additional Paid In Capital 33316000 33316000 33316000
Capital Stock 165968000 165968000 165968000
Common Stock 165968000 165968000 165968000

Income statement interpretation for Medico Remedies Limited

The income statement in the financial statement of the company shows its company financial performance over a period in time.

It consists of the following:

  • Revenue: It is the total amount of money earned from the core business activity of the company.
  • Expenses: It is the total amount required for running the full functionality of the company.
  • Profit or loss:In very simple terms, when a company pays its expenses using its revenue, then what’s left is profit, and in case expenses are more when compared with revenue, then it is loss.
đź“ŚRevenue & Profitability
Revenue/Profitability
Value & Year
2024
2023
2022
Total Revenue 1433103000 1384981000 1183489000
Operating Revenue 1433103000 1384981000 1183489000
Cost Of Revenue 1185963000 1127275000 957266000
Gross Profit 247140000 257706000 226223000
Ebitda 177362000 161203000 114265000
Ebit 119774000 106793000 69897000
Operating Income 100301000 68994000 53091000
Net Income 82909000 72415000 48120000
Net Income From Continuing Operation Net Minority Interest 82909000 72415000 48120000
Net Income From Continuing And Discontinued Operation 82909000 72415000 48120000
Net Income Common Stockholders 82909000 72415000 48120000
Net Income Including Noncontrolling Interests 82909000 72415000 48120000
Net Income Discontinuous Operations - - -
Net Income Continuous Operations 82909000 72415000 48120000
Normalized Income 82884129 72415000 49551798
Normalized Ebitda 177328000 161203000 116194000
Total Unusual Items 34000 - -1929000
Total Unusual Items Excluding Goodwill 34000 - -1929000
đź“ŚExpenses & Taxes
Expenses/Taxes
Value & Year
2024
2023
2022
Reconciled Depreciation 57588000 54410000 44368000
Reconciled Cost Of Revenue 1185963000 1127275000 957266000
Total Expenses 1332802000 1315987000 1130398000
Operating Expense 146839000 188712000 173132000
Other Operating Expenses 7266000 120000 4616000
Depreciation And Amortization In Income Statement 28794000 27205000 22184000
Amortization - - -
Depreciation Income Statement 28794000 27205000 22184000
Selling General And Administration 67680000 123243000 118631000
Selling And Marketing Expense 39277000 96025000 90283000
General And Administrative Expense 28403000 27218000 28348000
Rent And Landing Fees - 734000 315000
Tax Provision 30440000 28574000 16710000
Pretax Income 113349000 100989000 64830000
Other Non Operating Income Expenses 21235000 39466000 20290000
Special Income Charges 34000 - -1929000
Other Special Charges -34000 12000 391000
Write Off - - 1538000
Net Non Operating Interest Income Expense -7298000 -6463000 -5919000
Total Other Finance Cost 1810000 1667000 1555000
Interest Expense Non Operating 6425000 5804000 5067000
Interest Income Non Operating 937000 1008000 703000
đź“Ś Earnings Per Share
Earnings Per Share
Value & Year
2024
2023
2022
Diluted Eps 1.00 0.87 0.58
Basic Eps 1.00 0.87 0.58
Diluted Ni Avail To Com Stockholders 82909000 72415000 48120000
Net Income From Continuing Operations 82909000 72415000 48120000
Minority Interests - - -

Cash flow analysis for Medico Remedies Limited

The cashflow statement in the financial statement of the company shows how cash is moving in or moving out of the company over a period of time.

It consists of the following:

  • Operating activities: Cash flow from the core business operations.
  • Investing activities: Cashflow from investments made by the company.
  • Financing activities: These are cash from loans or by issuing shares or paying out dividends.
đź“ŚOperating Cash Flow
Operating Cash Flow
Value & Year
2024
2023
2022
Operating Cash Flow 26827000 81672000 58620000
Changes In Cash -4839000 -2536000 -16654000
Taxes Refund Paid -31664000 -24950000 -17947000
Change In Working Capital -92595000 -21484000 -13430000
Change In Other Current Liabilities -283000 -1930000 -6996000
Change In Other Current Assets 6390000 7561000 49014000
Change In Payable 5262000 38890000 17489000
Change In Inventory 33615000 -15910000 -35567000
Change In Receivables -136569000 -55569000 -38850000
Other Non Cash Items 267000 1288000 2279000
Stock Based Compensation - - -
Provision And Write Off Of Assets 6262000 -1387000 313000
Depreciation And Amortization 57588000 54410000 44368000
Amortization Cash Flow - - -
Depreciation 57588000 54410000 44368000
đź“ŚInvesting Cash Flow
Investing Cash Flow
Value & Year
2024
2023
2022
Investing Cash Flow -26766000 -66035000 -17564000
Net Other Investing Changes - - 1000
Interest Received Cfi 937000 711000 597000
Dividends Received Cfi - - -
Net Investment Purchase And Sale -975000 -868000 -137000
Sale Of Investment - - -
Purchase Of Investment -975000 -868000 -137000
Net Business Purchase And Sale - - -
Sale Of Business - - -
Purchase Of Business - - -
Net Ppe Purchase And Sale -24703000 -65878000 -29025000
Sale Of Ppe 80000 45000 30100000
Purchase Of Ppe -24783000 -65923000 -59125000
Net Intangibles Purchase And Sale - - -
Purchase Of Intangibles - - -
đź“Ś Financing Cash Flow
Financing Cash Flow
Value & Year
2024
2023
2022
Financing Cash Flow -4900000 -18173000 -57710000
Net Other Financing Charges - -13048000 1000
Interest Paid Cff - -525000 -2332000
Cash Dividends Paid - - -
Common Stock Dividend Paid - - -
Net Common Stock Issuance - - 124500000
Common Stock Payments - - -
Common Stock Issuance - - 124500000
Repurchase Of Capital Stock - - -
Repayment Of Debt - -13048000 -53879000
Issuance Of Debt - - -
Issuance Of Capital Stock - - 124500000
Net Issuance Payments Of Debt - -13048000 -53879000
Net Short Term Debt Issuance - - -3900000
Short Term Debt Issuance - - -
Net Long Term Debt Issuance - -13048000 -53879000
Long Term Debt Payments - -13048000 -53879000
Long Term Debt Issuance - - -
Net Preferred Stock Issuance - - -
Preferred Stock Payments - - -

Summary

Fundamental Overview of MEDICO.NS (Medico Remedies Limited)

Above is the summary for fundamental analysis of Medico Remedies Limited , whose ticker name is MEDICO.NS and belongs to sector Healthcare, and it is listed in NSE (National Stock Exchange).

The Medico Remedies Limited which is listed in NSE (National Stock Exchange) has a PE ratio of 55.84, MEDICO.NS has a net profit margin of 0.06, the acid test ratio for MEDICO.NS is 1.34, MEDICO.NS has an inventory turnover of 7.26, and MEDICO.NS has debt-to-equity ratio of 0.15.

The MEDICO.NS whose company name is Medico Remedies Limited has made profit/loss of 247140000 with total revenue of 1433103000, MEDICO.NS has assets worth of 961953000.

1. What is fundamental analysis?

Fundamental analysis is looking into a company’s real business performance by analyzing financial statements, earning reports, and key valuation ratios.

Basically, fundamental analysis involves examining a company’s revenue, profits, losses, debts, assets, liabilities, and ratios calculated using these values to determine long-term investment strategies.

Fundamental analysis may not work for short-term trading of stock; it is usually incorporated by long-term investors.

2. Importance of Fundamental Analysis

Imagine you are locking a good amount of funds into an unknown company for many years. Sounds stupid, right?

This is where fundamental analysis comes into the picture, which turns an unknown enemy into a known friend.

As fundamental analysis involves calculating how a company is actually performing, the real revenue, profits, assets, liabilities, debts, and more. This helps investors to determine what the actual current financial condition of the company is, how much the company’s stock price is justified when compared to earnings (Corporate earnings reports India) that it is making through business, what the probability is that the company will go bankrupt in the future, how much growth the company has shown in the past, and other financial ratios.

All these calculations and analyses determine the financial health of the company, historical business growth, company’s efficiency, and its stock price compared with real earnings (Corporate earnings reports India), which helps traders to make investment decisions for long-term investment strategies.

2. How to Use Our Tool

  • Search for the stock that you want to analyze in the search bar by typing the name of the company or ticker.
  • Once you land on the Stock Analytics Page, click on “Fundamental Analysis”; this will take you to the fundamental analysis page.
  • Apply Filter
  • On the “Fundamental Analysis” page, the first tab is for “Summary and Ratio,” where in the top section you can find the overall summary of the stock’s fundamental analysis, where on the leftmost side it has a textual summary, then in the middle a gauge chart that represents overall financial health, and then a list of important ratios.
  • Apply Filter
  • Then in the same “Summary and Ratio” tab, we have included a detailed analysis of stock in various aspects, which includes “Profitability Analysis,” “Liquidity Analysis,” “Efficiency Analysis,” “Coverage Analysis,” Solvency Analysis,” and “Market Analysis,” which divide the stock’s fundamentals into the above aspects and analyze each in the same format as for overall analysis, where the leftmost side has a textual summary, then in the middle a gauge chart that represents overall analysis of the particular section, and then a list of important ratios. Required for the particular analysis.
  • Apply Filter